Seeking Alpha

Abbott Labs (ABT) completes the separation of AbbVie (ABBV), its R&D-based pharmaceuticals...

Abbott Labs (ABT) completes the separation of AbbVie (ABBV), its R&D-based pharmaceuticals business that will start trading on the NYSE today. Wells Fargo maintains an "Outperform" rating on Abbott's shares, citing the company's above-average growth outlook and opportunities to significantly increase its margin. Wells Fargo sets Abbott a price target of $33-$34; its shares are $32.25 premarket.(PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs